Bloomberg on MSN3h
Harris Has 'Narrow' Path to Win Election, Evercore's Bianchi SaysSarah Bianchi, Evercore ISI chief strategist of political affairs and public policy, says some of the exit-poll data are ...
In this article, we are going to take a look at where GE Vernova Inc. (NYSE:GEV) stands against the other AI stocks that you ...
In a report released today, Glenn Schorr from Evercore ISI maintained a Hold rating on TPG (TPG – Research Report), with a price target ...
Proxies for former President Donald Trump's trade policies — specifically bitcoin and the Chinese yuan — can help gauge what market participants are making of the election results, Julian Emanuel, ...
The ride-hailing pioneer is contending with slowing bookings growth, rising insurance costs and an alliance between DoorDash and Lyft.
Evercore ISI analyst Liisa Bayko maintained a Buy rating on BioCryst (BCRX – Research Report) today and set a price target of $10.00. The ...
Despite witnessing modest growth in demand over the past three months, Apellis Pharmaceuticals’ complement inhibitor for ...
Madrigal’s Rezdiffra has launched a new MASH market, but ‘tremendous change’ is on the horizon
With the FDA approval of the first specific drug for Metabolic Associated Steatohepatitis (MASH) in March this year, Madrigal’s Rezdiffra is a pioneer in a market set for rapid change. | With the FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback